1 to 10 of 29 literature results

• Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029.

  Expression of the tetraspanin CO-029 is associated with poor prognosis in patients with gastrointestinal cancer. In a pancreatic tumor line, overexpre…

  Authors: Sabine Gesierich, Igor Berezovskiy, Eduard Ryschich, Margot Zöller

  Source: Cancer research. 2006 Jul 15

  View Full Text

• Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma.

  In a mouse model of hepatocellular carcinogenesis, highly vascularized tumors develop through two distinct morphologic phases of neovascularization. W…

  Authors: Eduard Ryschich, Paulius Lizdenis, Carina Ittrich, Axel Benner, Simone Stahl, Alf Hamann, Jan Schmidt, Percy Knolle, Bernd Arnold, Günter J Hämmerling,…

  Source: Cancer research. 2006 Jan 1

  View Full Text

• Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.

  In a transgenic mouse model of multistep carcinogenesis, highly angiogenic insulinomas contain an irregular vascular network and develop an intrinsic …

  Authors: Ruth Ganss, Eduard Ryschich, Ernst Klar, Bernd Arnold, Günter J Hämmerling

  Source: Cancer research. 2002 Mar 1

  View Full Text

• Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo.

  BACKGROUND: Adoptive cell transfer is described as an innovative and challenging option for the treatment of malignant melanoma. In the current study,…

  Authors: Jan Schmidt, Eduard Ryschich, Elisabeth Sievers, Ingo G H Schmidt-Wolf, Markus W Büchler, Angela Märten

  Source: Cancer. 2006 Feb 15

  View Full Text

• Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer.

  OBJECTIVES: The pathogenesis of pancreatic carcinoma is driven by the tumor cells ability to migrate causing invasion and metastases. The correlation …

  Authors: Eduard Ryschich, Akmal Khamidjanov, Vachtang Kerkadze, Markus W Büchler, Margot Zöller, Jan Schmidt

  Source: Pancreas. 2009 Oct

  View Full Text

• Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.

  Recent findings suggest that the presence of cancer stem cells could be linked with patients' survival. We profiled suggested cancer stem cell markers…

  Authors: Alexei V Salnikov, Grace Kusumawidjaja, Vanessa Rausch, Helge Bruns, Wolfgang Gross, Akmal Khamidjanov, Eduard Ryschich, Martha-Maria Gebhard, Gerhard Moldenhauer, Markus W Büchler,…

  Source: Cancer letters. 2009 Mar 18

  View Full Text

• Different radiogenic effects on microcirculation in healthy pancreas and in pancreatic carcinoma of the rat.

  OBJECTIVE: To compare the radiogenic effects on microcirculation in healthy and malignant pancreatic tissue. SUMMARY BACKGROUND DATA: Vascular injury …

  Authors: Eduard Ryschich, Jan Schmidt, Thorsten Loeffler, Michel Eble, Martha Maria Gebhard, Wolfgang Harms, Ernst Klar

  Source: Annals of surgery. 2003 Apr

  View Free Full Text

• Induction of an antitumoral immune response by wild-type adeno-associated virus type 2 in an in vivo model of pancreatic carcinoma.

  We analyzed the immunologic impact of adeno-associated virus type 2 (AAV-2), a small single-stranded parvovirus with tumorsuppressive properties, on D…

  Authors: Sven Eisold, Jan Schmidt, Eduard Ryschich, Michael Gock, Ernst Klar, Magnus von Knebel Doeberitz, Michael Linnebacher

  Source: Pancreas. 2007 Jul

  View Full Text

• Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.

  Patients with pancreatic cancer have a poor survival rate, and new therapeutic strategies are needed. Epithelial cell adhesion molecule (EpCAM), sugge…

  Authors: Alexei V Salnikov, Ariane Groth, Anja Apel, Georgios Kallifatidis, Benjamin M Beckermann, Akmal Khamidjanov, Eduard Ryschich, Markus W Büchler, Ingrid Herr, Gerhard Moldenhauer

  Source: Journal of cellular and molecular medicine. 2009 Sep

  View Full Text

• Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background.

  BACKGROUND: A novel pancreatic carcinoma cell line, FAMPAC, was identified from investigation of poorly differentiated pancreatic adenocarcinoma cells…

  Authors: Sven Eisold, Eduard Ryschich, Michael Linnebacher, Thomas Giese, Dirk Nauheimer, Anja Wild, Detlef K Bartsch, Markus W Büchler, Jan Schmidt

  Source: Cancer. 2004 May 1

  View Full Text